Barclays’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Hold
0
-$8K 4917
2022
Q2
Hold
0
4688
2022
Q1
Hold
0
4550
2021
Q4
Hold
0
4012
2021
Q3
Hold
0
4313
2021
Q2
Sell
-1
Closed -$164K 4228
2021
Q1
$109K Buy
+1
New +$220K ﹤0.01% 3965
2020
Q4
Hold
0
4512
2020
Q3
Sell
-2
Closed -$315K 4571
2020
Q2
$247K Buy
+2
New +$245K ﹤0.01% 3901
2020
Q1
Hold
0
6251
2019
Q4
Hold
0
6514

Other funds holding GNPX

Barclays's GNPX Position: Q3 2022 in Review

Barclays held its Genprex (GNPX) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4917.

Barclays first reported a position in GNPX in Q2 2020 and has held it in 2 quarters since. The position peaked at $247K in Q2 2020. 19 funds tracked by Wall St. Rank hold GNPX as of Q3 2022.

  • Barclays held 0 shares of Genprex worth $0 as of Q3 2022.
  • Barclays left its Genprex share count unchanged in Q3 2022.
  • Genprex made up ﹤0.01% of Barclays's portfolio in Q3 2022, its #4917 holding.
  • Barclays first reported a position in Genprex in Q2 2020 and has held it in 2 quarters since.
  • Barclays's Genprex position peaked at $247K in Q2 2020.
  • 19 funds tracked by Wall St. Rank held Genprex as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.